Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-25-018232
Filing Date
2025-04-17
Accepted
2025-04-17 16:24:30
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-17

Document Format Files

Seq Description Document Type Size
1 ARS esperion2024arproof.pdf ARS 17552670
  Complete submission text file 0001628280-25-018232.txt   24063198
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-35986 | Film No.: 25847642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)